News and Announcements
Folkestone Returns to Profit in FY13
- Published August 26, 2013 9:21AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX ANNOUNCEMENT
Folkestone (ASX: FLK) today announced its full year result for the year ending 30 June 2013.
Key Highlights:
- 1st full year net profit in 5 years
- Significant increase in funds under management to more than $630 million
- Acquisition of Austock property funds management business
- Two new unlisted real estate income funds closed oversubscribed
- Strong sales at the Officer residential land sub-division
- Stage 1a at The Ranges, Karratha opened and 38 lots of the 41 settled in Stage 1a
- Share price increase of 84 per cent in FY13
The past year was a major milestone for the company with the completion of the transformation of Folkestone from a real estate developer to a real estate funds manager, investor and developer providing real estate wealth solutions to private clients and select institutions.
To read full ASX announcement, please download the document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
